Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten O Nielsen

Showing results (71-80 of 212) with videos related to

Pageof 22
Sort By:
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Histopathology|August 23, 2023
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trialTorsten O Nielsen, Samuel C Y Leung, Nazia Riaz, et al.
Breast Cancer Research and Treatment|June 22, 2020
Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
The Journal of Molecular Diagnostics : JMD|November 7, 2017
Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter PlatformKenneth T E Chang, Angela Goytain, Tracy Tucker, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Histopathology|May 31, 2012
Variable performance of commercial epidermal growth factor receptor antibodies in detection of basal-like breast cancerJennifer R Won, Dongxia Gao, Dennis Grant, et al.
Histopathology|November 2, 2021
SRY-box transcription factor 10 is a highly specific biomarker of basal-like breast cancerKristina-Ana Klaric, Nazia Riaz, Karama Asleh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 2020
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor typesMayanne M T Zhu, Samantha Burugu, Dongxia Gao, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 21, 2005
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probeJefferson Terry, Todd S Barry, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Metastatic behavior of breast cancer subtypesHagen Kennecke, Rinat Yerushalmi, Ryan Woods, et al.
Pageof 22

Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Breast Cancer Research and Treatment|February 12, 2009
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patientsShuzhen Liu, Stephen K Chia, Erika Mehl, et al.
Histopathology|August 23, 2023
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trialTorsten O Nielsen, Samuel C Y Leung, Nazia Riaz, et al.
Breast Cancer Research and Treatment|June 22, 2020
Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
The Journal of Molecular Diagnostics : JMD|November 7, 2017
Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter PlatformKenneth T E Chang, Angela Goytain, Tracy Tucker, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Histopathology|May 31, 2012
Variable performance of commercial epidermal growth factor receptor antibodies in detection of basal-like breast cancerJennifer R Won, Dongxia Gao, Dennis Grant, et al.
Histopathology|November 2, 2021
SRY-box transcription factor 10 is a highly specific biomarker of basal-like breast cancerKristina-Ana Klaric, Nazia Riaz, Karama Asleh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 2020
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor typesMayanne M T Zhu, Samantha Burugu, Dongxia Gao, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 21, 2005
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probeJefferson Terry, Todd S Barry, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Metastatic behavior of breast cancer subtypesHagen Kennecke, Rinat Yerushalmi, Ryan Woods, et al.
Pageof 22